News

FDA approves MSD’s Keytruda to treat head and neck cancer
MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...
PMLive8h
Merck’s perioperative Keytruda regimen approved by FDA for head and neck cancer
Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...
2 Wonderful Dividends Practically Giving Themselves Away
Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...
Medical Dialogues4h
FDA Approves Keytruda as First Immune Checkpoint Inhibitor for Resectable Locally Advanced Head and Neck Cancer
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck ...
Investornewsbreaks Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response In Advanced NSCLC Patient In HARMONIC(TM) Trial
Lantern Pharma (NASDAQ: LTRN) announced a remarkable clinical outcome in its Phase 2 HARMONIC(TM) trial, with a 70-year-old never-smoker with advanc ...
Stockhead on MSN17h
Health Check: A pancreatic cancer ‘cure’ has been elusive, but Amplia may have cracked the nut
Amplia Therapeutics has reported a 'complete response' from a patient with metastasised pancreatic cancer: "A rare event". ..